ad image

Topical

1 / 1
Hovione
Phase II

Hovione Announces Successful End-of-Phase 2 Meeting with the FDA and Outlines Phase 3 Program for Minocycline Topical Gel

Hovione

PR-M09-19-NI-047Sep 20, 2019
Bausch Health Companies Inc.
FDA Approval

Bausch Health's BRYHALI™(halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults

Bausch Health Companies Inc.

PR-M10-18-NI-033Oct 10, 2018
Nuvo Pharmaceuticals
Acquisition

Nuvo Pharmaceuticals Inc.™ Acquires Global ex-U.S. Product Rights and existing Royalty Streams to Resultz® from Piedmont Pharmaceuticals LLC

Nuvo Pharmaceuticals

PR-M01-18-NI-006Jan 03, 2018
Mylan
Drug Delivery

Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace® Cream

Mylan

PR-M01-18-NI-005Jan 03, 2018
New NSAID Topical Gels Penetrate Three Times Faster
Topical

New NSAID Topical Gels Penetrate Three Times Faster

Guy Tiene

Nice Insight

PAO-M11-17-NI-004Nov 02, 2017
Topical Drug Formulations – Strong Growth Based on New Understandings: Q&A with BASF Pharma Solutions

Topical Drug Formulations – Strong Growth Based on New Understandings: Q&A with BASF Pharma Solutions

Nice Insight; Amy Ethier, Ph.D.; Norman Richardson

PAO-M04-17-NI-014Apr 12, 2017
1 / 1